老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
GraniteShares YieldBOOST Biotech ETF
20.28
-0.0059
-0.03%
盤後:
20.28
0.0050
+0.02%
19:19 EDT
成交量:
1,356
成交額:
2.75萬
市值:
101.38萬
市盈率:
- -
高:
20.28
開:
20.25
低:
20.25
收:
20.28
52周最高:
25.28
52周最低:
20.07
股本:
5.00萬
流通股本:
5.00萬
量比:
0.74
換手率:
2.71%
股息:
4.92
股息率:
24.28%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI
新华财经
·
08/31
聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進
证券日报
·
08/30
南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。
智通财经
·
08/28
據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。
智通财经
·
08/28
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BIOY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BIOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","market":"US","secType":"STK","nameCN":"GraniteShares YieldBOOST Biotech ETF","latestPrice":20.275,"timestamp":1789761600000,"preClose":20.28087,"halted":0,"volume":1356,"hourTrading":{"tag":"盘后","latestPrice":20.28,"preClose":20.275,"latestTime":"19:19 EDT","volume":56,"amount":1112.15,"timestamp":1789773549489,"change":0.005,"changeRate":0.000247,"amplitude":0},"delay":0,"changeRate":-0.0002894353151517463,"floatShares":50001,"shares":50001,"eps":0,"marketStatus":"休市中","change":-0.00587,"latestTime":"09-18 16:00:00 EDT","open":20.25,"high":20.28,"low":20.25,"amount":27476.131704,"amplitude":0.001479,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":20.28087,"nav":20.466384,"aum":1023339.649884,"dividendRate":0.242834,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":20.28,"preClose":20.275,"latestTime":"19:19 EDT","volume":56,"amount":1112.15,"timestamp":1789773549489,"change":0.005,"changeRate":0.000247,"amplitude":0},"volumeRatio":0.7413077403286893},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIOY\",,,,,undefined,":{"symbol":"BIOY","floatShares":50001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7413077403286893,"shares":50001,"dividePrice":4.92346,"high":20.28,"amplitude":0.001479,"preClose":20.28087,"low":20.25,"week52Low":20.07,"pbRate":"--","week52High":25.28,"institutionHeld":0,"latestPrice":20.275,"eps":0,"divideRate":0.242834,"volume":1356,"delay":0,"ttmEps":0,"open":20.25,"prevYearClose":25.12,"prevWeekClose":20.3312,"prevMonthClose":21.2744,"prevQuarterClose":23.15,"fiveDayClose":20.3312,"twentyDayClose":21.375,"sixtyDayClose":23.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIOY\",params:#limit:5,,,undefined,":[{"date":"2026-09-18","symbol":"BIOY","amount":0.23413,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-18","defaultRemindTime":1789738200000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-22","payableDate":"2026-09-18","currency":"USD","dateTimestamp":1789704000000,"payDate":"2026-09-22"},{"date":"2026-09-11","symbol":"BIOY","amount":0.24645,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-11","defaultRemindTime":1789133400000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-15","payableDate":"2026-09-11","currency":"USD","dateTimestamp":1789099200000,"payDate":"2026-09-15"},{"date":"2026-09-04","symbol":"BIOY","amount":0.24791,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-04","defaultRemindTime":1788528600000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-09","payableDate":"2026-09-04","currency":"USD","dateTimestamp":1788494400000,"payDate":"2026-09-09"},{"date":"2026-08-28","symbol":"BIOY","amount":0.24728,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-28","defaultRemindTime":1787923800000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-01","payableDate":"2026-08-28","currency":"USD","dateTimestamp":1787889600000,"payDate":"2026-09-01"},{"date":"2026-08-21","symbol":"BIOY","amount":0.24904,"announcedDate":"2026-08-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-21","defaultRemindTime":1787319000000,"name":"GraniteShares YieldBOOST Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-25","payableDate":"2026-08-21","currency":"USD","dateTimestamp":1787284800000,"payDate":"2026-08-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIOY\",market:\"US\",,,undefined,":[{"executeDate":"2026-05-08","recordDate":"2026-05-08","paymentDate":"2026-05-12","value":0.28187,"currency":"USD"},{"executeDate":"2026-05-15","recordDate":"2026-05-15","paymentDate":"2026-05-19","value":0.29042,"currency":"USD"},{"executeDate":"2026-05-22","recordDate":"2026-05-22","paymentDate":"2026-05-27","value":0.2758,"currency":"USD"},{"executeDate":"2026-05-29","recordDate":"2026-05-29","paymentDate":"2026-06-02","value":0.27453,"currency":"USD"},{"executeDate":"2026-06-05","recordDate":"2026-06-05","paymentDate":"2026-06-09","value":0.2676,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIOY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIOY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663282078","title":"藥聞 | 英硅智能上市後首份半年報扭虧 創新藥研發加速擁抱AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282078","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663282078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 15:35","pubTimestamp":1788161758,"startTime":"0","endTime":"0","summary":"新华财经上海8月31日电(记者杜康)作为AI制药领域代表性企业之一,英硅智能(03696.HK)日前发布2026年度中期业绩报告。上半年,公司实现总营收1.063亿美元,同比增长287.2%;净利润3554万美元,经调整净利润5123万美元,经营活动现金流转正。这是英硅智能上市后发布的首份半年报,公司也由此前的亏损转为盈利。从收入结构看,药物研发与管线开发仍是主要来源。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860072952.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860072952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CHAT","XLVI","GDOC","QTOC","VTHR","IPOS","WRND","BK4585","AIPO","APXH","PBE","SBIO","GSKH","AGIX","BIOY","BK4588","ARTY","BBP","LFSC","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044177","title":"聯環藥業上半年扭虧為盈 集採續採與創新藥研發協同推進","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044177","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044177?lang=zh_tw&edition=fundamental","pubTime":"2026-08-30 21:12","pubTimestamp":1788095520,"startTime":"0","endTime":"0","summary":"业绩实现扭亏为盈经营基本面持续改善今年上半年,联环药业经营业绩实现明显改善。对此,联环药业正持续推进相关工作。值得注意的是,联环药业已经开始围绕创新药商业化进行营销体系布局。除LH-1801外,联环药业产品注册申报也取得阶段性进展。从核心产品稳定销售,到集采品种持续放量,再到创新药研发向上市申报环节推进,联环药业正在逐步形成多层次的业务增长支撑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-30/doc-iniqcfmp8061523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["APXH","BK4588","PBE","BIOY","BK0239","600513","BBP","IBB","SBIO","XLVI","GDOC","LFSC","WRND","BK4585","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091790","title":"南京諾令生物科技股份有限公司向港交所提交上市申請書,獨家保薦人為建銀國際。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662091790?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 22:53","pubTimestamp":1787928801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","IPOS","BIOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662942093","title":"據港交所文件,維眸生物科技股份有限公司-B向港交所提交上市申請書。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662942093","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662942093?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 20:52","pubTimestamp":1787921537,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["TBXU","IPOS","BIOY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BIOY\",params:#limit:6,delay:false,,,undefined,":[]}}